Onco-GPCR Signaling and Dysregulated Expression of MicroRNAs in Human Cancer

Overview

Journal J Hum Genet

Specialty Genetics

Date 2016 Oct 14

PMID 27734836

Citations 11

Authors

Nijiro Nohata

Yusuke Goto

J Silvio Gutkind

Affiliations

Soon will be listed here.

Abstract

The G-protein-coupled receptor (GPCR) family is the largest family of cell-surface receptors involved in signal transduction. Aberrant expression of GPCRs and G proteins are frequently associated with prevalent human diseases, including cancer. In fact, GPCRs represent the therapeutic targets of more than a quarter of the clinical drugs currently on the market. MiRNAs (miRNAs) are also aberrantly expressed in many human cancers, and they have significant roles in the initiation, development and metastasis of human malignancies. Recent studies have revealed that dysregulation of miRNAs and their target genes expression are associated with cancer progression. The emerging information suggests that miRNAs play an important role in the fine tuning of many signaling pathways, including GPCR signaling. We summarize our current knowledge of the individual functions of miRNAs regulated by GPCRs and GPCR signaling-associated molecules, and miRNAs that regulate the expression and activity of GPCRs, their endogenous ligands and their coupled heterotrimeric G proteins in human cancer.

Citing Articles

A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal.

Qualliotine J, Nakagawa T, Rosenthal S, Sadat S, Ballesteros-Merino C, Xu G Cancers (Basel). 2023; 15(17).

PMID: 37686653 PMC: 10486378. DOI: 10.3390/cancers15174379.

The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.

Burlacu C, Neag M, Mitre A, Sirbu A, Badulescu A, Buzoianu A Int J Mol Sci. 2022; 23(10).

PMID: 35628263 PMC: 9141783. DOI: 10.3390/ijms23105452.

Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits.

Patel K, Bhat F, Patil S, Routray S, Mohanty N, Nair B Front Oncol. 2021; 11:660696.

PMID: 34136393 PMC: 8200776. DOI: 10.3389/fonc.2021.660696.

Post-transcriptional suppression of G protein-coupled receptor 15 (GPR15) by microRNA-1225 inhibits proliferation, migration, and invasion of human colorectal cancer cells.

Guo Y, Zhu Q, Chen S, Li Y, Fu D, Qiao D 3 Biotech. 2021; 11(3):139.

PMID: 33708462 PMC: 7902748. DOI: 10.1007/s13205-021-02682-2.

Development of Novel -In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours.

Poret B, Desrues L, Bonin M, Pedard M, Dubois M, Leduc R Biomolecules. 2020; 10(3).

PMID: 32204509 PMC: 7175314. DOI: 10.3390/biom10030471.

References

Cornelio D, Roesler R, Schwartsmann G . Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol. 2007; 18(9):1457-66. DOI: 10.1093/annonc/mdm058. View

Xue Q, Sun K, Deng H, Lei S, Dong J, Li G . MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened. Jpn J Clin Oncol. 2013; 44(1):13-21. DOI: 10.1093/jjco/hyt181. View

Young D, Waitches G, Birchmeier C, Fasano O, Wigler M . Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell. 1986; 45(5):711-9. DOI: 10.1016/0092-8674(86)90785-3. View

Zhou H, Rigoutsos I . MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells. RNA. 2014; 20(9):1431-9. PMC: 4138326. DOI: 10.1261/rna.045757.114. View

Lu Y, Sweredoski M, Huss D, Lansford R, Hess S, Tirrell D . Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126. ACS Chem Biol. 2013; 9(2):334-8. PMC: 3944050. DOI: 10.1021/cb400704n. View

Luo H, Wang Z, Sheng Y, Zhang Q, Yan J, Hou J . MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol. 2013; 31(1):789. DOI: 10.1007/s12032-013-0789-z. View

Zhang H, Wang Q, Zhao Q, Di W . MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res. 2013; 6(1):84. PMC: 3879084. DOI: 10.1186/1757-2215-6-84. View

Zou A, Lambert D, Yeh H, Yasukawa K, Behbod F, Fan F . Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins. BMC Cancer. 2014; 14:781. PMC: 4221705. DOI: 10.1186/1471-2407-14-781. View

Haug B, Henriksen J, Buechner J, Geerts D, Tomte E, Kogner P . MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis. 2011; 32(7):1005-12. DOI: 10.1093/carcin/bgr073. View

10.

Berthebaud M, Riviere C, Jarrier P, Foudi A, Zhang Y, Compagno D . RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood. 2005; 106(9):2962-8. DOI: 10.1182/blood-2005-02-0526. View

11.

Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rotzschke O, Falk K . CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood. 2004; 105(7):2877-86. DOI: 10.1182/blood-2004-07-2505. View

12.

Miyake M, Lawton A, Goodison S, Urquidi V, Gomes-Giacoia E, Zhang G . Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer. 2013; 13:322. PMC: 3708804. DOI: 10.1186/1471-2407-13-322. View

13.

McCabe J, Leahy D . Smoothened goes molecular: new pieces in the hedgehog signaling puzzle. J Biol Chem. 2014; 290(6):3500-7. PMC: 4319017. DOI: 10.1074/jbc.R114.617936. View

14.

Lu Z, Zhang W, Gao S, Jiang Q, Xiao Z, Ye L . MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochem Biophys Res Commun. 2015; 468(1-2):8-13. DOI: 10.1016/j.bbrc.2015.11.008. View

15.

Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang H . MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Oncotarget. 2015; 6(39):41638-49. PMC: 4747178. DOI: 10.18632/oncotarget.5873. View

16.

Rosenbaum D, Rasmussen S, Kobilka B . The structure and function of G-protein-coupled receptors. Nature. 2009; 459(7245):356-63. PMC: 3967846. DOI: 10.1038/nature08144. View

17.

Rasheed S, Teo C, Beillard E, Voorhoeve P, Zhou W, Ghosh S . MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Mol Cancer. 2015; 14:67. PMC: 4379695. DOI: 10.1186/s12943-015-0337-x. View

18.

Gao Y, Fan X, Li W, Ping W, Deng Y, Fu X . miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124. Biochem Biophys Res Commun. 2014; 446(1):179-86. DOI: 10.1016/j.bbrc.2014.02.073. View

19.

Rosano L, Bagnato A . Endothelin therapeutics in cancer: Where are we?. Am J Physiol Regul Integr Comp Physiol. 2016; 310(6):R469-75. PMC: 4867375. DOI: 10.1152/ajpregu.00532.2015. View

20.

Schutyser E, Struyf S, Van Damme J . The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003; 14(5):409-26. DOI: 10.1016/s1359-6101(03)00049-2. View